Different expression of estrogen receptors α and β in human myometrium and leiomyoma during the proliferative phase of the menstrual cycle and after GnRHa treatment

Gynecological Endocrinology

Volumn 15, Issue 6, 2001, Pages 443-452

  Wang, H ^a   Wu, X ^a   Englund, K ^a   Masironi, B ^a   Eriksson, H ^a   Sahlin, L ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Estrogen receptor; Leiomyoma; Uterus

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GONADORELIN DERIVATIVE; GOSERELIN; MESSENGER RNA; RECEPTOR PROTEIN; RECEPTOR SUBTYPE;

ADULT; ARTICLE; BENIGN TUMOR; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; MENSTRUAL CYCLE; MYOMETRIUM; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SOLUTION HYBRIDIZATION; TREATMENT OUTCOME; UTERUS MYOMA;

EID: 0035702334     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.1080/gye.15.6.443.452     Document Type: Article

References (32)

1. Analysis of androgen receptor DNA reveals the independent clonal origins of uterine leiomyomata and the secondary nature of cytogenic aberrations in the development of leiomyomata
2. Leiomyomas in pregnancy: Sonographic study
3. Estrogen and progesterone receptor and hormone levels in human myometrium and placenta in term pregnancy
4. Enzyme immunoassay of estrogen and progesterone receptors in uterine and intrauterine tissue during human pregnancy
5. Distribution of the A and B forms of the progesterone receptor messenger ribonucleic acid and protein in uterine leiomyomata and adjacent myometrium
6. Sex steroid receptors in human myometrium and fibroids: Changes during the menstrual cycle and gonadotropin-releasing hormone treatment
7. Luteinizing hormone-releasing hormone agonist and uterine leiomyoma: A pilot study
8. Fasting serum growth hormone and insulin-like growth factor-I and II concentrations in women with leiomyoma uteri treated with leuprolide acetate or placebo
9. The use of GnRH analogues in menorrhagia, contraception and uterine fibroids
10. Cloning of a novel estrogen receptor expressed in rat prostate and ovary
11. Estrogen receptor beta acts as a dominant regulator of estrogen signaling
12. Pathophysiology of uterine leiomyomas
13. Increased expression of estrogen receptor β in human uterine smooth muscle at term
14. Dexametasone attenuates the estradiolinduced increase of IGF-I mRNA in the rat uterus
15. A comparative study of estrogen receptors α and β in the rat uterus
16. Estrogen receptors α and β in the rodent mammary gland
17. Fibroid and myometrial steroid receptors in women treated with gonadotropin-releasing hormone agonist leuprolide acetate
18. Steroid receptor binding and messenger RNA expression in fibroids from untreated and gonadotropin-releasing hormone agonist pretreated women
19. Comparative messenger ribonucleic acid analysis of immediate early genes and sex steroid receptors in human leiomyoma and healthy myometrium
20. Immunohistochemical study of the proliferation index, estrogen receptors and progesterone receptors A and B in leiomyomata and normal myometrium during the menstrual cycle and under gonadotropin-releasing hormone agonist therapy
21. Treatment of uterine fibroids with implants of gonadotropin-releasing hormone agonist: Assessment by hysterography
22. Total and unbound cytosolic estrogen and progesterone receptors in myometrium and fibroid after gonadotropin-releasing hormone agonist treatment
23. Localization and expression of the human estrogen receptor beta gene in uterine leiomyomata
24. Estrogen receptors (ERα/ERβ) in normal and pathological growth of the human myometrium: Pregnancy and leiomyoma
25. Activation of the ovalbumin gene by the estrogen receptor involves the fos-jun complex
26. Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer
27. Tissue differences but limited sex steroid responsiveness of c-fos and c-jun in human fibroids and myometrium
28. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites
29. Estrogen and progesterone receptor content of GnRH analogue pretreated and untreated uterine leiomyomata
30. Estrogen receptor (ER) β, a modulator of ERα in the uterus